Bali Pulendran
Tracked across 2 events · 12 articles · First seen Feb 19, 2026 · Last active May 27, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Bali Pulendran, director of the Institute for Immunity, Transplantation and Infection at Stanford University School of Medicine, is the lead author of the study and believes the vaccine could be available within five to seven years.
Feb 19, 2026 · 6 articles
Tech
Impact: Bali Pulendran is the senior author of a separate Stanford University School of Medicine study on a universal nasal spray vaccine, offering a different approach to influenza protection.
Apr 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Bali Pulendran live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard